Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Chen, Linlin ^a   Zou, Yiyou ^a   Peng, Jie ^a   Lu, Fanggen ^b   Yin, Yani ^a   Li, Fujun ^a   Yang, Junwen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; PROBIOTIC AGENT; RNA; SODIUM CHLORIDE; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; IL17A PROTEIN, MOUSE; IL23A PROTEIN, MOUSE; INTERLEUKIN 23P19; STAT3 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; FEMALE; IMMUNOHISTOCHEMISTRY; LACTOBACILLUS ACIDOPHILUS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TH17 CELL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; COLITIS; DOWN REGULATION; IMMUNOLOGY; METABOLISM;

ANIMALS; COLITIS; DOWN-REGULATION; FEMALE; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; LACTOBACILLUS ACIDOPHILUS; MICE; MICE, INBRED BALB C; PROBIOTICS; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929340454     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/909514     Document Type: Article

References (35)

1. Q.-Q. Chen, L. Yan, C.-Z. Wang et al. , "Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses, "World Journal of Gastroenterology, vol. 19, no. 29, pp. 4702-4717, 2013.
2. A. Geremia, P. Biancheri, P. Allan, G. R. Corazza, and A. Di Sabatino, "Innate and adaptive immunity in inflammatory bowel disease, " Autoimmunity Reviews, vol. 13, no. 1, pp. 3-10, 2014.
3. L. A. Zenewicz, A. Antov, and R. A. Flavell, "CD4 T-cell differentiation and inflammatory bowel disease, " Trends in Molecular Medicine, vol. 15, no. 5, pp. 199-207, 2009.
4. F. J. D. Mennechet, L. H. Kasper, N. Rachinel, W. Li, A. Vandewalle, and D. Buzoni-Gatel, "Lamina propria CD4+ T lymphocytes synergize withmurine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen, " The Journal of Immunology, vol. 168, no. 6, pp. 2988-2996, 2002.
5. M. Rossi and A. Bot, "TheTh17 cell population and the immune homeostasis of the gastrointestinal tract, " International Reviews of Immunology, vol. 32, no. 5-6, pp. 471-474, 2013.
6. E. Troncone, I. Marafini, F. Pallone, and G. Monteleone, "Th17 cytokines in inflammatory bowel diseases: discerning the good fromthe bad, " International Reviews of Immunology, vol. 32, no. 5-6, pp. 526-533, 2013.
7. V. Hölttä, P. Klemetti, H. M. Salo et al. , "Interleukin-17 immunity in pediatric crohn disease and ulcerative colitis, " Journal of Pediatric Gastroenterology and Nutrition, vol. 57, no. 3, pp. 287-292, 2013.
8. A. Ueno, H. Jijon, R. Chan et al. , "Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity betweenTh17 and regulatory T cells in inflammatory bowel disease patients, " Inflammatory Bowel Diseases, vol. 19, no. 12, pp. 2522-2534, 2013.
9. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, "IL-17 and Th17 cells, " Annual Review of Immunology, vol. 27, pp. 485-517, 2009.
10. X. Zeng, Y. L. Wei, J. Huang et al. , " T cells recognize a microbial encoded B cell antigen to initiate a rapid antigenspecific interleukin-17 response, " Immunity, vol. 37, no. 3, pp. 524-534, 2012.
11. L. K. Fogli, M. S. Sundrud, S. Goel et al. , "T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia, " Journal of Immunology, vol. 191, no. 6, pp. 3100-3111, 2013.
12. D. V. Jovanovic, J. A. di Battista, J. Martel-Pelletier et al. , "IL-17 stimulates the production and expression of proinflammatory cytokines, IL- and TNF- , by human macrophages, " Journal of Immunology, vol. 160, no. 7, pp. 3513-3521, 1998.
13. Z.-J. Liu, P. K. Yadav, J.-L. Su, J.-S. Wang, and K. Fei, "Potential role of Th17 cells in the pathogenesis of in flammatory bowel disease, " World Journal of Gastroenterology, vol. 15, no. 46, pp. 5784-5788, 2009.
14. N. Yosef, A. K. Shalek, J. T. Gaublomme et al. , "Dynamic regulatory network controlling TH 17 cell differentiation, " Nature, vol. 496, no. 7446, pp. 461-468, 2013.
15. X. O. Yang, A. D. Panopoulos, R. Nurieva et al. , "STAT3 regulates cytokine-mediated generation of inflammatory helper T cells, "The Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358-9363, 2007.
16. L. Zhou, J. E. Lopes, M. M. W. Chong et al. , "TGF-induced Foxp3 inhibits T 17 cell differentiation by antagonizing ROR t function, " Nature, vol. 453, no. 7192, pp. 236-240, 2008.
17. C. J. Haines, Y. Chen, W. M. Blumenschein et al. , "Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23, " Cell Reports, vol. 3, no. 5, pp. 1378-1388, 2013.
18. G. L. Stritesky, N. Yeh, and M. H. Kaplan, "IL-23 promotes maintenance but not commitment to the Th17 lineage, " Journal of Immunology, vol. 181, no. 9, pp. 5948-5955, 2008.
19. E. Toussirot, "The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases, " Inflammation and Allergy-Drug Targets, vol. 11, no. 2, pp. 159-168, 2012.
20. L.-L. Chen, Y.-Y. Zou, F.-G. Lu, F.-J. Li, and G.-H. Lian, "Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis, " World Journal of Gastroenterology, vol. 19, no. 32, pp. 5347-5356, 2013.
21. E. Miyauchi, T. Ogita, J. Miyamoto et al. , "Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules, " PLoS ONE, vol. 8, no. 11, Article ID e79735, 2013.
22. S. I. Siakavellas and G. Bamias, "Role of the IL-23/IL-17 axis in Crohn's disease. , " Discovery medicine, vol. 14, no. 77, pp. 253-262, 2012.
23. M. Sarra, F. Pallone, T. T. MacDonald, and G. Monteleone, "IL-23/IL-17 axis in IBD, " Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1808-1813, 2010.
24. J. Dupaul-Chicoine, M. Dagenais, and M. Saleh, "Crosstalk between the intestinal microbiota and the innate immune system in intestinal homeostasis and inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 19, no. 10, pp. 2227-2237, 2013.
25. C. O. Elson and Y. Cong, "Host-microbiota interactions in inflammatory bowel disease, " Gut Microbes, vol. 3, no. 4, pp. 332-344, 2012.
26. R. L. Jan, K. C. Yeh, M. H. Hsieh et al. , "Lactobacillus gasseri suppresses Th17 pro-inflammatory response and attenuates allergen-induced airway inflammation in a mouse model of allergic asthma, " British Journal of Nutrition, vol. 108, no. 1, pp. 130-139, 2012.
27. S. Amdekar, V. Singh, A. Kumar, P. Sharma, and R. Singh, "Lactobacillus casei and lactobacillus acidophilus regulate inflammatory pathway and improve antioxidant status in collageninduced arthritic rats, " Journal of Interferon and Cytokine Research, vol. 33, no. 1, pp. 1-8, 2013.
28. L. R. Fitzpatrick, L. Deml, C. Hofmann et al. , "4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1763-1777, 2010.
29. M. Leppkes, C. Becker, I. I. Ivanov et al. , "ROR -expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F, " Gastroenterology, vol. 136, no. 1, pp. 257-267, 2009.
30. L. R. Fitzpatrick, J. S. Small, R. Doblhofer, and A. Ammendola, "Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action, " Journal of Pharmacology and Experimental Therapeutics, vol. 342, no. 3, pp. 850-860, 2012.
31. B. del Zotto, G. Mumolo, A. M. Pronio, C. Montesani, R. Tersigni, and M. Boirivant, "TGF- 1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis, " Clinical and Experimental Immunology, vol. 134, no. 1, pp. 120-126, 2003.
32. M. W. Babyatsky, G. Rossiter, and D. K. Podolsky, "Expression of transforming growth factors and in colonic mucosa in inflammatory bowel disease, " Gastroenterology, vol. 110, no. 4, pp. 975-984, 1996.
33. Z. Liu, P. K. Yadav, X. Xu et al. , "The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity, " Journal of Leukocyte Biology, vol. 89, no. 4, pp. 597-606, 2011.
34. Z. Zhang, A. Andoh, H. Yasui et al. , "Interleukin-1beta and tumor necrosis factor-alpha upregulate interleukin-23 subunit p19 gene expression in human colonic subepithelial myofibroblasts, " International Journal of Molecular Medicine, vol. 15, no. 1, pp. 79-83, 2005.
35. D. Ghadimi, U. Helwig, J. Schrezenmeir, K. J. Heller, and M. de Vrese, "Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system, " Journal of Leukocyte Biology, vol. 92, no. 4, pp. 895-911, 2012.